Cody Sean Deforest, | |
309 Main St, Salmon, ID 83467-4114 | |
(208) 742-3784 | |
Not Available |
Full Name | Cody Sean Deforest |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 309 Main St, Salmon, Idaho |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679259121 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | P10698 (Idaho) | Primary |
Mailing Address | Practice Location Address |
---|---|
Cody Sean Deforest, 309 Main St, Salmon, ID 83467-4114 Ph: () - | Cody Sean Deforest, 309 Main St, Salmon, ID 83467-4114 Ph: (208) 742-3784 |
News Archive
WageWorks, Inc., a leader in administering Consumer-Directed Benefits, today announced a partnership with Summit Health, a leading provider of on-site wellness, health screening and immunization programs. In this partnership, WageWorks will offer Summit Health's wellness services to its clients. Additionally, Summit Health clients will have access to WageWorks' Health Savings Accounts (HSAs) and Health Reimbursement Arrangements (HRAs).
Depression is on the rise among adolescents in the United States; in fact, according to the NIH, an estimated 3.2 million U.S. teenagers experience major depression each year.
HealthPort, a top-25 company in the healthcare information technology industry, today announced that Bridge Community Health Clinic in Wausau, Wisconsin has partnered with the company to implement three of HealthPort's technology solutions: HealthPort Practice Management (PM), HealthPort Electronic Medical Record (EMR); and HealthPort Revenue Cycle Management (RCM). HealthPort serves approximately 12 percent of the community health centers (CHCs) nationwide making them a leading technology solutions provider for this increasingly important industry segment.
A new type of targeting chaperon protein HSP70 inhibitor QL47 was recently discovered by a team led by Prof. LIU Qingsong from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences to treat FLT3-ITD-positive acute myeloid leukemia (AML).
A recent study found no significant difference in the outcome for patients who received carotid artery stenting (CAS) at more than 30 days post-transient ischemic attack (TIA) or stroke versus those who received CAS at 30 days or less post-event.
› Verified 5 days ago
Kami Thimons, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1026 S Challis St, Salmon, ID 83467 Phone: 208-742-1285 | |
Ryan Scott Algate, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 203 S Daisy St, Salmon, ID 83467 Phone: 208-756-5672 Fax: 208-756-5757 | |
Dr. James Lon Harrington, PHARMD, MBA Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1200 Shoup St, Salmon, ID 83467 Phone: 208-756-2822 | |
Mr. Joel Rea, RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 203 S Daisy, Salmon, ID 83467 Phone: 208-756-5675 Fax: 208-756-5757 | |
Charles John Clark, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 203 So. Daisy, Salmon, ID 83467 Phone: 208-756-5672 Fax: 208-756-5757 | |
Dr. Brittany Marie Cole, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1200 Shoup St, Salmon, ID 83467 Phone: 208-756-1940 Fax: 208-756-1790 |